Cost Minimization Analysis (CMA) of XELOX versus MFOLFOX6 in the treatment of colorectal cancer in an universitary hospital in Brazil
Introduction: Cancer worldwide is a public health problem with a perspective of 20 million new cases by 2025. Colorectal cancer (CRC) is ranked the third most incident tumor in the world and the fourth in Brazil. Objectives: The purpose of this paper was to evaluate the effectiveness and to conduct...
Saved in:
Main Authors: | , , |
---|---|
Format: | Book |
Published: |
Instituto Nacional de Assistência Farmacêutica e Farmacoeconomia,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
Call Number: |
A1234.567 |
---|---|
Copy 1 | Available |